vadimezan has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Du, L; Gu, Z; Hu, Q; Li, F; Li, J; Liu, P; Pu, J; Tang, Q; Wang, J; Wang, X; Xie, Y; Zhou, Y | 1 |
1 other study(ies) available for vadimezan and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
A DNA/DMXAA/Metal-Organic Framework Activator of Innate Immunity for Boosting Anticancer Immunity.
Topics: Animals; Carcinoma, Hepatocellular; DNA; Immunity, Innate; Liver Neoplasms; Membrane Proteins; Metal-Organic Frameworks; Mice; Tumor Microenvironment | 2023 |